Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
The STAR Act passes in the U.S. House of Representatives.
by Brad Jones
The Breast Cancer Art Project encourages breast cancer patients and survivors to produce—and share—art about their cancer experiences.
by Ashley P. Taylor
An app developed for glioblastoma patients allows them to track their symptoms and contribute to research.
A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non–small cell lung cancer treatment.
In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.
Patients who opt for breast reconstruction after mastectomy tend to overestimate how happy they will be with the results, while those who do not get reconstruction tend to underestimate their future satisfaction.
Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.
by Cheryl Platzman Weinstock
Forward Look
Efforts are underway to define role of high-dose radiation.
by Stephen Ornes
Q&A
Research scientist Teresa Woodruff is determined to make fertility preservation accessible to more young adults and children with cancer.
by Delia O'Hara
The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients.
by Marci A. Landsmann
Many older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.
Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.
To defend against bacterial infections, cancer patients are often put on a neutropenic diet—which bars fresh fruits and vegetables, among other things. Research indicates that following this diet is unnecessary.
Older melanoma patients may respond to anti-PD1 immunotherapy better than younger patients, a study suggests.
The U.S. Food and Drug Administration approves a targeted therapy combination for thyroid cancer.
Ari M. Melnick, MD, discusses lymphoma research.
The Financial Toll of Cancer
donate to the AACR